[Novelties in arterial hypertension management in the last decade]

J M Krzesinski1, A Saint-Remy1

  • 1Service de Néphrologie, Dialyse et Transplantation, CHU Liège, Belgique.

Insights

Effective hypertension management remains a challenge, with recent guidelines emphasizing patient education, home monitoring, and combination therapies. Improved blood pressure control is crucial for cardiovascular protection.

Area of Science:

  • Cardiology
  • Public Health
  • Pharmacology

Background:

  • Hypertension is a primary cardiovascular risk factor with insufficient control despite numerous management efforts.
  • No new antihypertensive drugs have been released in the past decade, shifting focus to non-pharmacological interventions.
  • High blood pressure, often termed the 'silent killer,' necessitates improved control strategies.

Purpose of the Study:

  • To review current strategies for managing hypertension.
  • To highlight the impact of recent guidelines on hypertension treatment.
  • To emphasize the importance of multi-faceted approaches for better blood pressure control.

Main Methods:

  • Review of recent guidelines and therapeutic approaches for hypertension management.
  • Emphasis on patient validation, home blood pressure monitoring, and therapeutic education.
  • Discussion of treatment decisions based on cardiovascular risk and the role of combination therapy.

Main Results:

  • New, simplified guidelines released in 2018 aim to improve hypertension control.
  • European guidelines maintain a blood pressure target below 140/90 mmHg for most patients.
  • Combination therapy in a single pill is recommended for enhanced treatment efficacy.

Conclusions:

  • Improved blood pressure control requires a collaborative effort involving patients, families, nurses, and pharmacists.
  • Adherence to guidelines and combination therapies are key to achieving optimal cardiovascular protection.
  • Enhanced patient education and home monitoring are vital for managing this prevalent cardiovascular risk factor.

Related Concept Videos

Hypertension IV: Drug Therapy and Lifestyle Modifications01:28

Hypertension IV: Drug Therapy and Lifestyle Modifications

Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
464
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
800
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists01:18

Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists

Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
340
Antihypertensive Drugs: Vasodilators01:23

Antihypertensive Drugs: Vasodilators

Vasodilators, primarily affecting the smooth muscles within arterial and venous walls, are commonly used for hypertension treatment. Medications such as minoxidil and hydralazine primarily target arteries and arterioles, while sodium nitroprusside acts on arterioles and venules. Minoxidil, functioning as a prodrug, is metabolized by hepatic sulfotransferase into its active form, minoxidil sulfate, after oral administration. This metabolite binds to the sulfonylurea receptor (SUR) component of...
1.9K
Antihypertensive Drugs: Direct Renin Inhibitors01:25

Antihypertensive Drugs: Direct Renin Inhibitors

The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
1.1K
Antihypertensive Drugs: Angiotensin II Receptor Blockers01:30

Antihypertensive Drugs: Angiotensin II Receptor Blockers

In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
2.2K